We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH Taps Eli Lilly’s COVID-19 Antibody for Two Trials
NIH Taps Eli Lilly’s COVID-19 Antibody for Two Trials
The National Institutes of Health (NIH) launched two clinical trials yesterday of Eli Lilly’s experimental monoclonal antibody LY-CoV555 for the treatment for COVID-19 patients.